(ABT:New York Consolidated)
Earnings & Estimates Summary - ABBOTT LABORATORIES (ABT)
2013 revenues at Abbott Laboratories totaled $21.8B USD, while annual earnings equaled $2.01 per share.
Quarterly Earnings & Estimates - ABBOTT LABORATORIES (ABT)
Abbott Laboratories's Quarterly Earnings
Abbott Laboratories reported 2nd quarter 2014 earnings of $0.54 per share on 07/18/2014.
Annual Earnings & Estimates - ABBOTT LABORATORIES (ABT)
Abbott Laboratories's Annual Earnings
Abbott Laboratories reported annual 2013 earnings of $2.01 per share on 01/24/2014.
Quarterly Revenues - ABBOTT LABORATORIES (ABT)
Abbott Laboratories's Quarterly Revenues
Abbott Laboratories had 2nd quarter 2014 revenues of $5.6B USD. This bettered the $5.5B USD consensus of the 18 analysts covering the company. This was 1.9% above the prior year's 2nd quarter results.
Annual Revenues - ABBOTT LABORATORIES (ABT)
Abbott Laboratories's Annual Revenues
Abbott Laboratories had revenues for the full year 2013 of $21.8B USD. This was -45.2% below the prior year's results.
|AstraZeneca PLC||4,182 GBp||-66.00|
|Danaher Corp||$85.59 USD||-1.29|
|Eli Lilly & Co||$80.32 USD||-1.28|
|Teva Pharmaceutical Industries Ltd||$63.44 USD||-0.68|
|Thermo Fisher Scientific Inc||$121.17 USD||-1.60|
|View Industry Companies|